0001209191-23-016046.txt : 20230303
0001209191-23-016046.hdr.sgml : 20230303
20230303195733
ACCESSION NUMBER: 0001209191-23-016046
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230301
FILED AS OF DATE: 20230303
DATE AS OF CHANGE: 20230303
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Kassberg Thomas Richard
CENTRAL INDEX KEY: 0001303811
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36276
FILM NUMBER: 23707064
MAIL ADDRESS:
STREET 1: C/O ULTRAGENYX PHARMACEUTICAL INC.
STREET 2: 60 LEVERONI COURT
CITY: NOVATO
STATE: CA
ZIP: 94949
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Ultragenyx Pharmaceutical Inc.
CENTRAL INDEX KEY: 0001515673
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 272546083
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 60 LEVERONI COURT
CITY: NOVATO
STATE: CA
ZIP: 94949
BUSINESS PHONE: 415-483-8800
MAIL ADDRESS:
STREET 1: 60 LEVERONI COURT
CITY: NOVATO
STATE: CA
ZIP: 94949
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2023-03-01
0
0001515673
Ultragenyx Pharmaceutical Inc.
RARE
0001303811
Kassberg Thomas Richard
C/O ULTRAGENYX PHARMACEUTICAL INC.
60 LEVERONI COURT
NOVATO
CA
94949
0
1
0
0
CBO & EVP
Common Stock
2023-03-01
4
A
0
2663
0.00
A
230222
D
Common Stock
2023-03-01
4
A
0
22000
0.00
A
252222
D
Common Stock
2023-03-01
4
S
0
1968
45.27
D
250254
D
Common Stock
2023-03-01
4
D
0
3394
45.65
D
246860
D
Stock Option (Right to Buy)
45.65
2023-03-01
4
A
0
39400
0.00
A
2033-03-01
Common Stock
39400
39400
D
Represents shares of common stock which previously granted performance stock units were converted on March 1, 2023 upon certification of the performance metric.
Award of Restricted Stock Units ("RSUs") under the Company's 2014 Incentive Plan. The RSUs shall vest with respect to 1/4th of the underlying shares on each anniversary of the grant date, such that the RSUs are fully vested on the fourth anniversary of the grant date.
Represents shares sold to pay required tax withholdings due to the vesting of RSUs.
Shares were acquired upon the partial vesting of a previously reported RSU and were sold to permit the cash value of the awards to be credited to the deferred compensation plan account of the Reporting Person
Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions.
On the first anniversary of the grant date of the option (the "Option Anniversary Date"), 1/4th of the shares initially subject to the option shall vest; thereafter, 1/48th of the shares initially subject to the option shall vest on each month as measured from the Option Anniversary Date.
/s/ Karah Parschauer, attorney-in-fact
2023-03-03